Get a 7 minute blogcast on the 2nd annual Clinical Trials Collaboration conference. This program takes place April 3-4 in Boston. Led by Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, the CTC conference is the only strategic-level event in the US entirely focused on collaborations needed for 21st century drug development.
Tufts CSDD, Ken Getz will kick off the event with “How the Clinical Collaborations Landscape Is Changing and Its Impact on R&D Operations.” The CTC conference also will feature 3 first-time keynotes:
Takeda on their Transformational Clinical Development and Marketed Product Partnership with PRA Health Sciences with Dr Andy Plump, Director, Chief Medical and Scientific Officer, Takeda
Models for Exquisite Project Delivery with Internal and External Partners with Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck
Big Trends Impacting Clinical Development with Dr Steve Cutler, COO and CEO Designate, ICON
In addition, the CTC conference will feature:
Clinical Research as a Care Option: This collaborative session scheduled for the entire afternoon of April 4 shows us how clinical trial professionals can bring patients closer to clinical research and can find ways to make clinical trials a care option. Dr John McConnell, CEO, Wake Forest University Medical, is confirmed to keynote this section of the conference.
For more information, visit www.theconferenceforum.org